SecBot SecBot
Insider Cluster (2 insiders) ·Filed Jun 26, 2026

IONS

IONIS PHARMACEUTICALS INC
NEUTRAL
Impact 2/10
Horizondays Processed4mo ago
Insider cluster: 2 insiders, $2.5M total
Actionable Insight • Neutral

Insider sales are routine and immaterial in size. No bearish read-through; the cluster is consistent with normal portfolio diversification by executives. Monitor for any upcoming pipeline catalysts (e.g., FDA decisions, Phase 3 data) that could drive the stock, but this filing itself does not warrant a trading response.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
IONS ▼ -43.30% at T+60d
NEUTRAL call -43.30% · α vs SPY -47.69% · entry $80.69 → $45.75
Entry = T+0 close
Jun 26, 2026
via day close
T+1d
-1.74%
call -1.74% · α -2.51%
$79.29
settled 4mo ago
T+5d
+3.09%
call +3.09% · α +1.70%
$83.18
settled 4mo ago
T+20d
-29.92%
call -29.92% · α -29.64%
$56.55
settled 3mo ago
T+60d
-43.30%
call -43.30% · α -47.69%
$45.75
settled 5w ago

Price Chart

Loading chart...

Executive Summary

CEO Monia Brett P and EVP Research Eric Swayze sold a combined ~$7.7M in open-market sales over a 3-day window, primarily from CEO option exercises and same-day sales. The total represents only ~0.06% of IONS' $12.9B market cap, making this a routine insider transaction cluster with no material bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$7.7M
Insiders
2

Key Facts

  • CEO Monia Brett P sold 85,637 shares across three days (June 24-26) for ~$6.83M, all tied to derivative exercises
  • EVP Research Eric Swayze sold 10,602 shares on June 25 for ~$839K
  • Total open-market sales of ~$7.67M represent 0.06% of IONS' $12.9B market cap
  • All CEO sales were same-day exercises of stock options (non-cash grants), indicating a routine tax/diversification pattern
  • No 10b5-1 plan disclosure, but the pattern of exercise-and-sell is typical of pre-arranged trading

Financial Impact

~$7.7M in insider sales, negligible relative to $12.9B market cap

insider ownershipfloat

Risk Factors

  • CEO selling could be misinterpreted by retail as bearish, but the dollar amount is trivial
  • Potential for additional insider sales if a 10b5-1 plan is active, but no evidence of abnormal selling pressure

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (33 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-IONS-1782515424445
24 reports for IONS
Performance horizon
57% Hit rate @ T+20 4 of 7 directional calls Went positive at some point 7 of 9 best @ T+60▲ +32.25%Jul 9, 2026
Filters
Rows
Reports for IONS — sortable, filterable
TypeNow
Oct 23, 2026
3d ago
8-K
BULLISH ★ 7/10
$42.93awaiting T+20—$43.42 (+1.14%)
Oct 21, 2026
5d ago
8-K
BULLISH ★ 7/10
$43.91awaiting T+20—$43.42 (−1.12%)
Oct 21, 2026
5d ago
Institutional Cluster
MIXED ★ 3/10
$43.91awaiting T+20—$43.42 (−1.12%)
Sep 23, 2026
4w ago
8-K
BULLISH ★ 7/10
$43.93 $44.27▲ +0.77%▲ +0.09%$43.42 (−1.16%)
Sep 4, 2026
7w ago
8-K
BEARISH ★ 7/10
$56.71 $44.00▲ +22.41%▲ +24.13%$43.42 (+23.44%)
Sep 4, 2026
7w ago
8-K
BULLISH ★ 7/10
$58.09 $43.50▼ −25.12%▼ −25.72%$43.42 (−25.25%)
Jul 31, 2026
12w ago
Insider Buy
NEUTRAL ★ 4/10
$54.49 $60.36▲ +10.77%▲ +9.53%$43.42 (−20.32%)
Jul 29, 2026
12w ago
8-K
MIXED ★ 6/10
$54.04 $63.36▲ +17.25%▲ +12.23%$43.42 (−19.65%)
Jul 9, 2026
15w ago
8-K
NEUTRAL ★ 2/10
$58.25 $56.56▼ −2.90%▼ −5.33%$43.42 (−25.46%)
Jul 9, 2026
15w ago
Insider Cluster
NEUTRAL ★ 2/10
$58.25 $56.56▼ −2.90%▼ −5.33%$43.42 (−25.46%)
Showing 10 of 24

US Market Status

Market Closed — Opens Tue (15h 55m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 26, 2026